Related Experiment Video
Updated: May 9, 2026

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration
Published on: January 6, 2014
Impact of Neutrophils on the Tissue Microenvironment During Intestinal Inflammation
Faiz Minhajuddin1, Sean P Colgan1,2, Ian M Cartwright1,2
1Mucosal Inflammation Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract:
Neutrophils (polymorphonuclear leukocytes, PMN) are abundant innate immune cells that rapidly accumulate at mucosal surfaces during inflammation. While their antimicrobial functions are essential for host defense, sustained PMN activation profoundly alters the tissue microenvironment, driving epithelial barrier disruption, ECM remodeling, metabolic imbalance, and microbiome dysbiosis. In chronic inflammatory diseases such as inflammatory bowel disease (IBD), these processes contribute to persistent tissue injury and therapeutic resistance. In this review, we synthesize evidence from human mucosal biopsies, experimental models of intestinal inflammation, and emerging single-cell, spatial, and metabolic approaches to define how PMN shape the inflamed mucosal microenvironment. We highlight mechanisms governing PMN recruitment, retention, and survival; effector programs including reactive oxygen species production, protease release, and PMN extracellular trap formation; and bidirectional crosstalk with epithelial, stromal, and immune cell compartments. We further discuss how PMN-driven metabolic and microbiome alterations reinforce chronic inflammation and influence responses to biologic therapy. Collectively, these insights reframe PMN as context-dependent regulators of mucosal pathology and repair and identify PMN-centered pathways as promising targets for precision therapies aimed at restoring barrier function and promoting durable inflammatory resolution.
Insights
Neutrophils (polymorphonuclear leukocytes, PMN) drive chronic inflammation and tissue damage in diseases like IBD. Targeting PMN pathways offers new precision therapies for restoring mucosal barrier function and resolving inflammation.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Neutrophils (polymorphonuclear leukocytes, PMN) are key innate immune cells that accumulate at mucosal surfaces during inflammation.
- Sustained PMN activation disrupts epithelial barriers, remodels extracellular matrix, causes metabolic imbalance, and dysregulates the microbiome.
- These PMN-driven processes contribute to persistent tissue injury and treatment resistance in chronic inflammatory diseases like inflammatory bowel disease (IBD).
Purpose of the Study:
- To synthesize current evidence on how PMNs shape the inflamed mucosal microenvironment.
- To highlight mechanisms of PMN recruitment, retention, survival, and effector functions.
- To discuss PMN-driven metabolic and microbiome alterations and their impact on therapy response.
Main Methods:
- Review of human mucosal biopsies and experimental models of intestinal inflammation.
- Integration of data from single-cell, spatial, and metabolic profiling approaches.
- Analysis of bidirectional crosstalk between PMNs and other tissue compartments.
Main Results:
- PMNs are recruited, retained, and survive in inflamed mucosa, executing effector programs like ROS production and NET formation.
- PMNs engage in complex crosstalk with epithelial, stromal, and immune cells.
- PMN activity significantly impacts host metabolism and the gut microbiome, influencing inflammation chronicity and therapeutic outcomes.
Conclusions:
- PMNs act as context-dependent regulators of mucosal pathology and repair.
- PMN-centered pathways represent promising targets for precision therapies.
- Targeting PMNs can restore barrier function and promote durable inflammatory resolution in IBD and other chronic inflammatory conditions.
Related Concept Videos
Inflammation
Acute Inflammation I: Cellular Phase
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Microbiota of the Stomach and Small Intestine
Chronic Inflammation: Introduction

